Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions

NCT03886766 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Biological Availability
Amorphous Solid Dispersions

Interventions

DRUG: Hot-melt extruded amorphous solid dispersion of Efavirenz
DRUG: Hot-melt extruded amorphous solid dispersion of Efavirenz homogenized to drug rich particles
DRUG: Efavirenz solution

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]